Literature DB >> 32109627

Who and when to vaccinate against influenza.

Philippe Buchy1, Selim Badur2.   

Abstract

Known since Hippocrates and of continuing public health importance, influenza remains a major cause of morbidity and mortality worldwide, and large segments of the human population are affected every year. Vaccination is the most effective means of preventing influenza infection. Today, many countries have implemented annual influenza vaccination programs, and there is increasing awareness of the potential societal and health benefits of vaccinating pregnant women, children aged 6 months to 5 years, older adults, and persons with underlying medical conditions that make them vulnerable to serious complications of influenza. In this non-systematic review, we summarize data on influenza epidemiology and influenza vaccine immunogenicity, efficacy/effectiveness, and safety in the main high-risk groups. We also discuss the optimal time to vaccinate and the effect of pre-existing immunity on vaccine response.
Copyright © 2020 GlaxoSmithKline Biologicals S.A. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Children; Chronic disease; Influenza; Older adults; Pregnant women; Risk groups; Vaccine

Year:  2020        PMID: 32109627     DOI: 10.1016/j.ijid.2020.02.040

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  6 in total

Review 1.  Bacterial Membrane Vesicles in Pneumonia: From Mediators of Virulence to Innovative Vaccine Candidates.

Authors:  Felix Behrens; Teresa C Funk-Hilsdorf; Wolfgang M Kuebler; Szandor Simmons
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

2.  3-Indoleacetonitrile Is Highly Effective in Treating Influenza A Virus Infection In Vitro and In Vivo.

Authors:  Xuejin Zhao; Lianzhong Zhao; Ya Zhao; Kun Huang; Wenxiao Gong; Ying Yang; Li Zhao; Xiaohan Xia; Zaiyun Li; Feng Sheng; Xuezhu Du; Meilin Jin
Journal:  Viruses       Date:  2021-07-23       Impact factor: 5.048

3.  Validity of the Health Belief Model Applied to Influenza among people with chronic diseases: Is it time to develop a new knowledge domain?

Authors:  Sladjana Arsenović; Goran Trajković; Tatjana Pekmezović; Tatjana Gazibara
Journal:  PLoS One       Date:  2022-09-15       Impact factor: 3.752

4.  The Role of Psychological Factors and Vaccine Conspiracy Beliefs in Influenza Vaccine Hesitancy and Uptake among Jordanian Healthcare Workers during the COVID-19 Pandemic.

Authors:  Malik Sallam; Ramy Mohamed Ghazy; Khaled Al-Salahat; Kholoud Al-Mahzoum; Nadin Mohammad AlHadidi; Huda Eid; Nariman Kareem; Eyad Al-Ajlouni; Rawan Batarseh; Nidaa A Ababneh; Mohammed Sallam; Mariam Alsanafi; Srikanth Umakanthan; Ala'a B Al-Tammemi; Faris G Bakri; Harapan Harapan; Azmi Mahafzah; Salah T Al Awaidy
Journal:  Vaccines (Basel)       Date:  2022-08-19

Review 5.  The Association between Influenza Vaccination and COVID-19 and Its Outcomes: A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Ruitong Wang; Min Liu; Jue Liu
Journal:  Vaccines (Basel)       Date:  2021-05-20

6.  The Potential Benefits of the Influenza Vaccination on COVID-19 Mortality Rate-A Retrospective Analysis of Patients in Poland.

Authors:  Kinga Izabela Stańczak-Mrozek; Adam Sobczak; Leszek Lipiński; Elżbieta Sienkiewicz; Dorota Makarewicz; Roman Topór-Mądry; Jarosław Pinkas; Radosław Adam Sierpiński
Journal:  Vaccines (Basel)       Date:  2021-12-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.